TAIHO PHARMA

We strive to
improve human
health and contribute
to a society enriched
by smiles

About Taiho

Becoming a truly global specialty pharma that meets the expectations of patients worldwide.

Our Business

Taiho Pharmaceutical creates innovative, highly valuable new drugs to support patients and the advancement of medicine, seeking to contribute to smiles and health for people all around the world.

News Releases

July 13, 2018

Taiho Pharmaceutical Enters into Development of a Novel Immuno-Oncology Therapy with Arcus Biosciences
July 03, 2018

Taiho Pharmaceutical Completes New Production Facility for Highly Potent Pharmaceutical Ingredients at Saitama Site
June 25, 2018

Taiho and Servier Present Promising Data on LONSURF^® (trifluridine and tipiracil) at ESMO 20th World Congress on Gastrointestinal Cancer 2018（PDF：182.4 KB）
May 28, 2018

Taiho Pharmaceutical to Launch Tiovita Drink Aibitasu Zero Nationwide on May 28, 2018 "No fatigue the next day!"
May 22, 2018

Taiho Pharmaceutical Announces the Launch in Japan of TREMFYA^® Subcutaneous Injection 100mg Syringe　(guselkumab), a Human Anti-interleukin (IL)-23p19 Monoclonal Antibody

Information

July 12, 2018

Announcement of Support from Otsuka Holdings and Its Group Companies in the Aftermath of Severe Storms in Japan（PDF：165.9 KB）